Jamilla Goedegebuur and Colleagues on VTE Management in Case of PAD
RPTH Journal shared on LinkedIn:
”How to manage VTE in patients with peripheral arterial disease
Patients with peripheral arterial disease routinely receive antithrombotic therapy, yet the optimal management of a VTE in this population remains uncertain.
Using nationwide Dutch data , this study highlights substantial variability in real-world practice and underscores the need for clear guidance and consensus in this complex clinical scenario.
Read the full article here.”
Article: Antithrombotic therapy in lower extremity peripheral artery disease patients with venous thromboembolism: a nationwide cohort study
Authors: Jamilla Goedegebuur, Elena Butera, Qingui Chen, Behnood Bikdeli, Walter Ageno, Roberto Pola, Angelo Porfidia, Stefano Barco, Thijs E. van Mens, Joost R. van der Vorst, Suzanne C. Cannegieter, Frederik
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 23, 2026, 19:30Jordan Agay: Why We Need to Track the Neurological Costs of Anemia
-
Jul 23, 2026, 19:25William Archibald: Key Takeaways on VTE Cost-Effectiveness and Cancer Associated Thrombosis from ISTH 2026
-
Jul 23, 2026, 19:17Diego López Santos: Donation after Donation, I Just Reached 100
-
Jul 23, 2026, 19:11Jecko Thachil: Chlorosis May Have Represented Iron Deficiency in the 19th Century
-
Jul 23, 2026, 15:58Mel Snyder: Beyond Sickle Cell Disease to the Future of Pediatric Genetics
-
Jul 23, 2026, 15:43Lorna Knight: The Next Frontier in Sickle Cell Disease Is Access
-
Jul 23, 2026, 15:29Ben Kleinstiver: Overcoming a Major Barrier to Scalable Gene Editing
-
Jul 23, 2026, 15:28Modernizing DIC Diagnosis in Cirrhosis: Building an International Registry for Precision Hemostasi
-
Jul 23, 2026, 14:32Saneha Anjum Shaikh: Why Antibody Screening Must Be Standard Practice in Modern Blood Banking